G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,667,000 | +33.7% | 69,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,247,000 | +52.4% | 69,300 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $818,000 | -51.1% | 70,800 | +2.6% | 0.00% | -50.0% |
| Q2 2020 | $1,674,000 | +101.9% | 69,000 | -8.3% | 0.00% | +100.0% |
| Q1 2020 | $829,000 | -59.7% | 75,262 | -3.3% | 0.00% | -50.0% |
| Q4 2019 | $2,058,000 | +34.5% | 77,862 | +15.9% | 0.00% | 0.0% |
| Q3 2019 | $1,530,000 | +58.4% | 67,162 | +113.2% | 0.00% | +100.0% |
| Q2 2019 | $966,000 | +75.6% | 31,500 | -4.9% | 0.00% | 0.0% |
| Q1 2019 | $550,000 | -40.1% | 33,126 | -30.9% | 0.00% | 0.0% |
| Q4 2018 | $918,000 | -65.5% | 47,951 | -5.9% | 0.00% | -66.7% |
| Q3 2018 | $2,664,000 | +62.1% | 50,951 | +34.8% | 0.00% | +50.0% |
| Q2 2018 | $1,643,000 | – | 37,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |